I am going to ask one question and then let Mr. Stewart ask the next one.
Mr. Gold, I am a Montreal member and, as you know, we have recently had a number of research centres shut down, in particular those of Johnson & Johnson, AstraZeneca and Sanofi Canada.
From what I understand, you do not believe that extending the terms of pharmaceutical companies' patents under free trade agreements will encourage pharmaceutical companies to increase their research and development investment in Canada or to keep their research centres in operation.